Literature DB >> 10986192

Eye disorders: bacterial conjunctivitis.

C W Chung1, E J Cohen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10986192      PMCID： PMC1071070          DOI： 10.1136/ewjm.173.3.202

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  16 in total

1.  Causes of conjunctivitis and keratoconjunctivitis in Karachi, Pakistan.

Authors:  R M Woodland; S Darougar; U Thaker; L Cornell; M Siddique; J Wania; M Shah
Journal:  Trans R Soc Trop Med Hyg       Date:  1992 May-Jun       Impact factor: 2.184

Review 2.  Complications of topical antimicrobial agents.

Authors:  G A Stern; D W Killingsworth
Journal:  Int Ophthalmol Clin       Date:  1989

3.  Antibacterial effectiveness of ciprofloxacin 0.3% ophthalmic solution in the treatment of bacterial conjunctivitis.

Authors:  H M Leibowitz
Journal:  Am J Ophthalmol       Date:  1991-10       Impact factor: 5.258

4.  Comparison of three topical antimicrobials for acute bacterial conjunctivitis.

Authors:  J A Lohr; R D Austin; M Grossman; G F Hayden; G M Knowlton; S M Dudley
Journal:  Pediatr Infect Dis J       Date:  1988-09       Impact factor: 2.129

5.  Prevalence of acute conjunctivitis caused by chlamydia, adenovirus, and herpes simplex virus in an ophthalmic casualty department.

Authors:  P K Wishart; C James; M S Wishart; S Darougar
Journal:  Br J Ophthalmol       Date:  1984-09       Impact factor: 4.638

6.  Acute conjunctivitis in childhood.

Authors:  A Weiss; J H Brinser; V Nazar-Stewart
Journal:  J Pediatr       Date:  1993-01       Impact factor: 4.406

7.  [A multicenter randomized study of fusidic acid ophthalmic gel and rifamycine eyedrops in acute conjunctivitis].

Authors:  J P Adenis; M Arrata; P Gastaud; S Limon; M Massin
Journal:  J Fr Ophtalmol       Date:  1989       Impact factor: 0.818

8.  Fusidic acid in infections of the external eye.

Authors:  O P van Bijsterveld; Y el Batawi; F S Sobhi; M W Nassar
Journal:  Infection       Date:  1987 Jan-Feb       Impact factor: 3.553

9.  Epidemiology and diagnosis of acute conjunctivitis at an inner-city hospital.

Authors:  C P Fitch; P A Rapoza; S Owens; F Murillo-Lopez; R A Johnson; T C Quinn; J S Pepose; H R Taylor
Journal:  Ophthalmology       Date:  1989-08       Impact factor: 12.079

10.  The safety and efficacy of topical norfloxacin compared with placebo in the treatment of acute, bacterial conjunctivitis. The Norfloxacin-Placebo Ocular Study Group.

Authors:  I M Miller; J Wittreich; R Vogel; T J Cook
Journal:  Eur J Ophthalmol       Date:  1992 Apr-Jun       Impact factor: 1.922
View more
  3 in total

1.  The role of topical moxifloxacin, a new antibacterial in Europe, in the treatment of bacterial conjunctivitis.

Authors:  Jose Benitez-Del-Castillo; Yves Verboven; David Stroman; Laurent Kodjikian
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

2.  Human conjunctival epithelial cells lack lipopolysaccharide responsiveness due to deficient expression of MD2 but respond after interferon-gamma priming or soluble MD2 supplementation.

Authors:  Jaya Talreja; Kavitha Dileepan; Sanjeev Puri; Mohammad H Kabir; David M Segal; Daniel J Stechschulte; Kottarappat N Dileepan
Journal:  Inflammation       Date:  2005-12       Impact factor: 4.092

3.  Potential bias in ophthalmic pharmaceutical clinical trials.

Authors:  Paul Varner
Journal:  Clin Ophthalmol       Date:  2008-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.